Plain Language Trial Resources

Additional information on the clinical trials that Lilly has in development can be found here.

BAFF-R x CD3 Bispecific T-Cell Engager

LY4152199
NCT07101328; BAF_FRontier‑1

BCL6 Molecular Glue

LY4584180
NCT07226843; NOVA‑BCL6‑1

FGFR3 Inhibitor

Vepugratinib
NCT05614739; FORAGER‑1

FGFR3 Inhibitor

Vepugratinib
NCT07218380; FORAGER‑2

KRAS G12C Inhibitor

Olomorasib
NCT06119581; SUNRAY‑01

For information on trial enrollment, locations, and more, call 1-877-285-4559.